- Home
- VNDA vs OZ Comparison
VNDA vs OZ Comparison
Compare VNDA & OZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- OZ
- Stock Information
- Founded
- VNDA 2002
- OZ 2020
- Country
- VNDA United States
- OZ United States
- Employees
- VNDA N/A
- OZ N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- OZ
- Sector
- VNDA Health Care
- OZ
- Exchange
- VNDA Nasdaq
- OZ Nasdaq
- Market Cap
- VNDA 237.9M
- OZ 236.3M
- IPO Year
- VNDA 2006
- OZ N/A
- Fundamental
- Price
- VNDA $4.22
- OZ $64.17
- Analyst Decision
- VNDA Strong Buy
- OZ
- Analyst Count
- VNDA 2
- OZ 0
- Target Price
- VNDA $16.50
- OZ N/A
- AVG Volume (30 Days)
- VNDA 500.0K
- OZ 6.9K
- Earning Date
- VNDA 05-07-2025
- OZ 01-01-0001
- Dividend Yield
- VNDA N/A
- OZ N/A
- EPS Growth
- VNDA N/A
- OZ N/A
- EPS
- VNDA N/A
- OZ N/A
- Revenue
- VNDA $201,351,000.00
- OZ $2,675,000.00
- Revenue This Year
- VNDA $14.36
- OZ N/A
- Revenue Next Year
- VNDA $44.53
- OZ N/A
- P/E Ratio
- VNDA N/A
- OZ N/A
- Revenue Growth
- VNDA 13.37
- OZ 18.68
- 52 Week Low
- VNDA $3.85
- OZ $56.77
- 52 Week High
- VNDA $6.75
- OZ $82.89
- Technical
- Relative Strength Index (RSI)
- VNDA 41.17
- OZ 54.82
- Support Level
- VNDA $4.20
- OZ $61.75
- Resistance Level
- VNDA $4.64
- OZ $64.50
- Average True Range (ATR)
- VNDA 0.17
- OZ 1.11
- MACD
- VNDA 0.01
- OZ 0.31
- Stochastic Oscillator
- VNDA 20.75
- OZ 90.44
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories.